Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

IMRIS Inc receives Australian regulatory clearance for intraoperative CT solution

Wednesday, 26 Feb 2014 08:00am EST 

IMRIS Inc:Obtained Therapeutic Goods Administration (TGA) regulatory listing for VISIUS iCT, the first and only ceiling-mounted intraoperative computed tomography, allowing for sales and marketing in Australia.Received U.S. Food and Drug Administration (FDA) 510(k) and CE mark clearance for VISIUS iCT in July 2013. 

Company Quote

0.06 +7.69%
24 Apr 2015